Biologics Market Research Report 2024-2030: Technological Innovations in Monoclonal Antibodies and Gene Therapies Fueling Developments and Growth Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Biologics was estimated...

Global Generic Oncology Drugs Markets to 2032: Rising Cancer Prevalence and Patent Expirations Propel Growth Dublin, March 22, 2024 (GLOBE NEWSWIRE) -- The "Generic Oncology Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032" report has been added to ...

Biologics Market Report 2024-2034 - Advances in Regenerative Medicine and Cell Biology Driving Market Growth Dublin, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The "Biologics Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. Revenue for the Biologics Market is forecast to surpass...

Oncology Biosimilar Market Size is projected to reach USD 15.62 billion by 2031, growing at a CAGR of 20.5%: Straits Research New York, United States, Nov. 23, 2022 (GLOBE NEWSWIRE) -- A biosimilar is a generic version of a well-known biologic drug. Biologic drugs are medicines made from living things like cells, tissues,...